Smoking and inflammation: Their synergistic roles in chronic disease

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cigarette smoking is a major risk factor for the development and progression of cardiovascular and other chronic diseases. Cigarette smoke increases inflammatory mediators in the circulation and generates high amounts of reactive oxygen species, which are potent triggers of the inflammatory response and thought to play a central role in the development of atherosclerosis. Low-grade inflammation, atherogenic lipoprotein profile, and hypercoagulability are characteristic of smokers, and smoking cessation has been associated with a rapid improvement in the inflammatory balance. In individuals with high risk of coronary disease, 1 year of smoking cessation significantly counteracts impaired endothelial function, as assessed by a decreased plasma level of intercellular adhesion molecule. This review focuses on the connection between smoking and inflammation and their role in chronic disease. © 2008 Current Medicine Group LLC.

Cite

CITATION STYLE

APA

Halvorsen, B., Otterdal, K., Tonstad, S., & Aukrust, P. (2008). Smoking and inflammation: Their synergistic roles in chronic disease. Current Cardiovascular Risk Reports. https://doi.org/10.1007/s12170-008-0079-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free